HL-300 Efficacy of Brentuximab Vedotin Plus Conventional Chemotherapy Regimens as Pre–Autologous Stem Cell Transplantation Re-Induction Salvage Therapy in Relapsed/Refractory Classical Hodgkin Lymphoma

Ridova, Nevenka; Ivanovski, Martin; Trajkova, Sanja; Pivkova Veljanovska, Aleksandra; Chadievski, Lazar; Dukovski, Dushko; Popova-Labachevska, Marija; Krstevska Balkanov, Svetlana; Stojanoski, Zlate; Stojanovska-Jakimovska, Simona; Cvetanoski, Milche; Milovska, Dijana; Grivchevska, Milena; Kochoski, Bozidar; Kostojchinoska, Viktorija; Jakjimovski, Mario; Panovska Stavridis, Irina

doi:10.1016/s2152-2650(22)01476-8

HL-300 Efficacy of Brentuximab Vedotin Plus Conventional Chemotherapy Regimens as Pre–Autologous Stem Cell Transplantation Re-Induction Salvage Therapy in Relapsed/Refractory Classical Hodgkin Lymphoma

Journal

Clinical Lymphoma Myeloma and Leukemia

Date Issued

2022-10

Author(s)

Ivanovski, Martin

Dukovski, Dushko

Popova-Labachevska, Marija

Stojanovska-Jakimovska, Simona

Milovska, Dijana

Grivchevska, Milena

Kochoski, Bozidar

Kostojchinoska, Viktorija

Jakjimovski, Mario

DOI

10.1016/s2152-2650(22)01476-8

File(s)

Name

HL-300 Efficacy of Brentuximab Vedotin Plus Conventional Chemotherapy Regimens as Pre–Autologous Stem Cell Transplantation Re-Induction Salvage Therapy in Relapsed Refractory Classical Hodgkin Lymphoma.pdf

Size

63.72 KB

Format

Adobe PDF

Checksum

(MD5):67d521ddaa894af72098f86180274511